Entries tagged "Novartis AG"
Midmarket pharmaceutical deals could increase as the FTC will likely ask for concessions in the form of divestitures resulting from the three megapharma deals announced earlier in the year.
Pharmaceutical/healthcare companies pumped up their offerings last week with three major acquisitions falling in the top 10 domestic deals of the week charts for the week ended April 11. Swiss pharmaceutical company Novartis AG registered the biggest U.S. deal of the week acquiring nearly 25% of eye-care provider Alcon Inc. from Nestlé SA for $10.5 billion on April 7. ...
The week started strong with deals in the drug industry, financial sector and some movement in the Microsoft Corp.-Yahoo! Inc. proposed transaction. Markets responded positively to the deal activity, increasing 84.75, or 0.67%, to 12,693.60 in Monday midday trading, and the Nasdaq inched up 13.66, or 0.58%, to 2384.64. Here's a closer look at the performance of stocks involved in deals: ...
